1. Home
  2. DARE vs NAII Comparison

DARE vs NAII Comparison

Compare DARE & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • NAII
  • Stock Information
  • Founded
  • DARE N/A
  • NAII 1980
  • Country
  • DARE United States
  • NAII United States
  • Employees
  • DARE N/A
  • NAII N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • NAII Medicinal Chemicals and Botanical Products
  • Sector
  • DARE Health Care
  • NAII Health Care
  • Exchange
  • DARE Nasdaq
  • NAII Nasdaq
  • Market Cap
  • DARE 27.9M
  • NAII 26.0M
  • IPO Year
  • DARE N/A
  • NAII 1987
  • Fundamental
  • Price
  • DARE $3.17
  • NAII $4.05
  • Analyst Decision
  • DARE Strong Buy
  • NAII
  • Analyst Count
  • DARE 4
  • NAII 0
  • Target Price
  • DARE $20.33
  • NAII N/A
  • AVG Volume (30 Days)
  • DARE 25.7K
  • NAII 4.9K
  • Earning Date
  • DARE 03-27-2025
  • NAII 02-14-2025
  • Dividend Yield
  • DARE N/A
  • NAII N/A
  • EPS Growth
  • DARE N/A
  • NAII N/A
  • EPS
  • DARE N/A
  • NAII N/A
  • Revenue
  • DARE $1,881,316.00
  • NAII $121,853,000.00
  • Revenue This Year
  • DARE N/A
  • NAII N/A
  • Revenue Next Year
  • DARE $136.52
  • NAII N/A
  • P/E Ratio
  • DARE N/A
  • NAII N/A
  • Revenue Growth
  • DARE 88.13
  • NAII N/A
  • 52 Week Low
  • DARE $2.67
  • NAII $4.02
  • 52 Week High
  • DARE $7.56
  • NAII $7.26
  • Technical
  • Relative Strength Index (RSI)
  • DARE 50.64
  • NAII 36.48
  • Support Level
  • DARE $2.95
  • NAII $4.08
  • Resistance Level
  • DARE $3.31
  • NAII $4.19
  • Average True Range (ATR)
  • DARE 0.15
  • NAII 0.11
  • MACD
  • DARE 0.01
  • NAII -0.01
  • Stochastic Oscillator
  • DARE 61.11
  • NAII 8.76

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

Share on Social Networks: